FDA calls Alibaba’s AI model for early pancreatic cancer screening a breakthrough
Damo Panda, an AI model used for early pancreatic cancer screening, has been officially designated as a breakthrough device by the US Food and Drug Administration (FDA), said its developer Alibaba-affiliated DAMO Academy on Thursday. Leveraging AI, the model can detect subtle lesions invisible to the human eye in CT images, thus improving scanning precision…